Comparison 2. NSAID versus NSAID.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Change in LBP pain intensity from baseline on 100 mm VAS, follow‐up <= 3 weeks	2		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
1.1 Meloxicam	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 Lornoxicam	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Global improvement	2		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 Diclofenac	2		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Side effects	2		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 Meloxicam 7.5/15mg vs. Diclofenac 150mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 Lornoxicam	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Number of participants with additional pain medication	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4.1 Meloxicam 7.5/15mg vs. Diclofenac	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]